WILMINGTON, Del. – Today, United States Attorney Benjamin L. Wallace announced the filing of civil claims against three defendants, Alpha Care Medical, LLC; its owner Nihar Gala, of Lewes, Delaware; and its laboratory director Bo Wang, of Glen Mills, Pennsylvania, in connection with an alleged scheme to defraud Medicare, Medicaid, TRICARE, and the Federal Employees Health Benefits Program through submission of false claims for laboratory diagnostic testing. The complaint filed in federal court is part of the Department of Justice’s 2026 National Health Care Fraud Takedown. In its complaint, the United States alleges that the defendants violated the False Claims Act by submitting thousands of claims to government healthcare programs for laboratory diagnostic tests that lacked a valid medical purpose to diagnose or treat patients, were conducted in violation of laboratory clinical standards that ensure reliability, and, in numerous cases, were not conducted at all. “As alleged, the defendants exploited federal health care programs for financial gain at the expense of patients and taxpayers,” said U.S. Attorney Wallace. “In the District of Delaware, we will continue to vigorously enforce the False Claims Act to protect patients, public funds, and the integrity of our health care system.”The civil claims announced by U.S. Attorney Wallace are part of a strategically coordinated, nationwide law enforcement action that resulted in charges against 455 defendants, including 90 doctors and other licensed medical professionals, for their alleged participation in health care fraud and opioid abuse schemes involving over $6.5 billion in false claims and significant patient harm, including death. The 2026 Takedown represents a new era in federal, state, and international cooperation to combat health care fraud: charges in 56 federal districts and involving 45 U.S. states and territories, the most in Department history. In addition, unprecedented international cooperation over the two-week Takedown resulted in the apprehension and return to the United States of the following health care fraudsters: one defendant in Kyrenia in connection with an over $3.7 billion scheme; two defendants in Estonia in connection with a previously charged $10.6 billion scheme; and, in the Philippines, one of FBI’s Most Wanted Fraudsters in connection with a $1.2 billion telemedicine scheme. The Takedown involves the cutting-edge use of data analytics to target the worst actors; seize over $182 million in cash, houses, luxury vehicles, jewelry, and other assets; and provide full spectrum accountability for all criminal actors from doctor’s offices to corporate boardrooms.Coordinated enforcement action involving a whole-of-government approach, includes: Actions by the Centers for Medicare and Medicaid Services (CMS) to suspend 1,079 providers and revoke billing privileges for 1,403 providers.48 Civil Monetary Payment settlements amounting to over $73 million, over 1,400 provider exclusions, and 25 actions by the U.S. Department of Health and Human Services, Office of Inspector General (“HHS-OIG”) under the Civil Monetary Penalties Law seeking more than $10 billion in payments to the Medicare Trust Fund from payments that CMS caught and suspended before the funds were paid to the fraudulent providers.Civil charges against 13 defendants for $14.8 million in health care fraud schemes, as well as civil settlements with 31 defendants totaling $23 million.928 administrative cases by the Drug Enforcement Administration (DEA) seeking the revocation of authority to handle and/or prescribe controlled substances since October 1, 2025.The cases are being prosecuted by the Health Care Fraud Unit’s National Rapid Response, Florida, Gulf Coast, Los Angeles, Midwest, New England, Northeast, Texas, and West Coast Strike Forces; U.S…
Source: U.S. Department of Justice